Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence



Rating:

Share or cite this content

Citations should be made in the following way:
C. Gessner (Leipzig, Germany), R. Van Zyl-Smit (Cape Town, South Africa), D. Singh (Manchester, United Kingdom), H. A.M. Kerstjens (Groningen, Netherlands), C. Raherison-Semjen (Bordeaux, France), D. Lawrence (Basel, Switzerland), A. Pethe (New Jersey, United States of America), A. Tanase (Basel, Switzerland), K. Mezzi (Basel, Switzerland), P. D'Andrea (New Jersey, United States of America). Mometasone/indacaterol demonstrates similar efficacy in men and women: pooled analyses of PALLADIUM and IRIDIUM studies. 3388

Member's Comments

No comment yet.

Related content which might interest you: Mometasone/ indacaterol/ glycopyrronium demonstrates similar efficacy in men and women: post hoc analysis of IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Pregnancy-adapted YEARS algorithm: can YEARS do more for pregnant women? Source: Breathe, 16 (1) 190307; 10.1183/20734735.0307-2019 Year: 2020 Effect of indacaterol/mometasone on lung function in adolescents versus overall patient population: PALLADIUM study Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL® non-interventional study Source: ERJ Open Res, 7 (3) 00004-2021; 10.1183/23120541.00004-2021 Year: 2021 Dexamethasone in patients hospitalized with COVID-19: a NNT and NNH analysis of RECOVERY study Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Prevalence of asthmatic smokers: Turkish experience (PASTE study) Source: Annual Congress 2008 - Tobacco smoking by population subgroups Year: 2008 Treatment patterns in stable COPD patients – results from a large observational European study (SPACE) Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Aero-allergen sensitization in a general population: data from the LEAD population cohort study Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Use of the Daily PROactive instrument to evaluate physical activity in patients with COPD: results from ACTIVATE Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 The ESCAPE study: design and exposure assessment results Source: Annual Congress 2013 –Highlights from ESCAPE Year: 2013 Reduction in fatal events with extrafine inhaled corticosteroid (ICS)-containing medications: results of stratified safety pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies. Source: International Congress 2018 – Clinical trials in COPD: new results Year: 2018 Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020 Gender and economic aspects of COPD in a Swedish cohort: The ARCTIC study Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) in ex-smoker and never smoker patients with inadequately controlled asthma: Post hoc analysis of IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Evaluation of roflumilast in COPD patients in a real-world European setting: results from the PROFILE EU study Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Cancer And Physical ACtivITY (CAPACITY) trial- A randomised control trial of exercise and self-management in lung cancer: preliminary feasibility results Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019 Treatable traits in the NOVELTY study: assessing complexity by network analysis Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Indacaterol/glycopyrronium (IND/GLY) reduces the risk of clinically important deterioration (CID) in patients with moderate COPD: Results from the CRYSTAL study Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Smoking cessation for COPD patients: preliminary results of the SMOKE study Source: Annual Congress 2004 - Smoking and cessation in respiratory disease Year: 2004